Sunday, February 19, 2017

Indian biosimilar market likely to touch $1 billion in three years

According to KPMG, the global life sciences industry is gradually moving from chemical-based drugs to biologics with the sales contribution of ...
Delivered by KPMG Today (@KPMG_TO)
Article continues here
Follow @KPMG_TO on Twitter to get latest updates